Clinical Trials Logo

Filter by:
NCT ID: NCT03232788 Recruiting - Clinical trials for Periodontal Diseases

Use of Scaffolds for Treatment of Gingival Recession Associated With Interproximal Tissue Deficiency

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

This study will seek to evaluate the predictability and efficacy of a Computer Aided Design-Computer Aided Manufacturing and additively manufactured polycaprolactone and hydroxyapatite scaffolds in these defects compared to traditional guided tissue regeneration. 40 gingival recessions associated with interproximal tissue deficiency will be divided into two groups: control group (autogenous bone + collagen membrane; n = 20) and test group (autogenous bone + scaffold; n = 20).

NCT ID: NCT03244241 Recruiting - Clinical trials for Type 2 Diabetes Mellitus

Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study

Start date: April 1, 2017
Phase: Phase 4
Study type: Interventional

Hyperglycemia during admission is associated with increased rate of complications and longer hospital stays, thus insulin treatment is recommended for all diabetes patients with hyperglycemia. Inpatient studies of non-critically ill patients show better glycemic control with the use of basal-bolus insulin therapy compared to sliding scale insulin therapy, but increased rates of hypoglycemia. The investigators hypothesize that basal-bolus insulin therapy with a new ultra-long-action basal insulin can treat hyperglycemia more efficiently than sliding scale insulin, with few episodes of hypoglycemia.

NCT ID: NCT03248076 Recruiting - Opioid Use Clinical Trials

Effect of Fentanyl on Main Opioid Receptor (OPRM1) on Human Granulosa Cells.

Start date: April 1, 2017
Phase: N/A
Study type: Observational

Opioids is known that produce not only analgesia but also hyperalgesia through activation of central glutaminergic system-GABA. At the same time, recently it was found that the main opioid receptor (OPRM1) is present on human granulosa cells and exogenous opiates and their antagonists can influence granulosa cell vascular endothelial growth factor (VEGF) production via OPRM1, causing ovarian hyperstimulation syndrome. This study aims to investigate if a single exposure to opioids is enough to produce activation of stress mechanism during oocyte retrieval.

NCT ID: NCT03256266 Recruiting - Intestine Disease Clinical Trials

Effect of Antigens or Therapeutic Agents on in Vitro Human Intestinal Organoids

Start date: April 1, 2017
Phase:
Study type: Observational

The study evaluates the effect of nutrient antigens or therapeutic agents on human small intestinal organoids.

NCT ID: NCT03263156 Recruiting - Insomnia Clinical Trials

A Brief Parent-based Sleep Intervention for ADHD Children

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

Sleep problems are very common in children with ADHD, with a prevalence rate as high as 73%, and often pose significant challenges and stress to the families. Sleep problems in ADHD children are strongly associated with the exacerbation of daytime symptoms, impaired physical health, and poor parental mental health. The present study is a randomised controlled trial to compare the effects of a parent-based sleep intervention for children with ADHD (aged 6-12). Eligible participants will be randomised to either intervention (two face-to-face consultation sessions and one follow-up phone call) or waiting-list control condition. Assessments will be conducted at pre-treatment (baseline), one-week after the intervention (post-treatment), and 3 months after the intervention.

NCT ID: NCT03263741 Recruiting - Gastric Cancer Clinical Trials

Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer

Start date: April 1, 2017
Phase: Phase 2
Study type: Interventional

Explore the Efficiency and Safety of Paclitaxel + S-1 + Oxaliplatin (PSOX) Chemotherapy in the Patients with Locally Advanced or Advanced Gastric Cancer

NCT ID: NCT03274908 Recruiting - Internal Disorders Clinical Trials

Real-world Clinical Study and Medical Machine Intelligence Study for Traditional Chinese Internal Medicine

Start date: April 1, 2017
Phase:
Study type: Observational [Patient Registry]

This real-world study aimed at 1. exploring the relationships of traditional Chinese medicine (TCM) syndrome and internal diseases, 2. investigating the relationships of TCM treatment and internal diseases, and 3. creating medical machine intelligence to help internal physician in clinical practice. Big data methods and artificial intelligence algorithms are used to assess the associations based on electronic case files of patients.

NCT ID: NCT03276611 Recruiting - Clinical trials for Obstructive Sleep Apnea of Adult

Assessment of Pulmonary Artery Pressure and Right Sided Hemodynamics in Patients With OSA Before and After CPAP TTT

Start date: April 1, 2017
Phase: N/A
Study type: Observational

Obstructive sleep apnea (OSA) is a frequent sleep-related breathing disorder with an incidence of 5-20% in the middle-aged population in Europe and Northern America . plumonary hypertension is present in 12%-34% of patients with osa.continous positive air way pressureis the main standard treatment ofOSA.Echocardiograghy is the most common non invasive imaging method for assessment the effect on right ventricular function.

NCT ID: NCT03294382 Recruiting - Scar Clinical Trials

Botulinum Toxin to Improve Results in Epicanthoplasty

Start date: April 1, 2017
Phase: Phase 3
Study type: Interventional

Medial epicanthal fold is a common skin fold in the inner part of the eye in more than 50% Asia population, giving the illusion of a shorter palpebral fissure length and a wider intercanthal distance. Currently, various epicanthoplasty techniques have been well described to correct epicanthus fold. However, hypertrophic scarring after epicanthoplasty remains a clinical challenge, which seems inevitable and may leading to unpleasing supratarsal crease, recurrence of medial epicanthus fold, even obvious scar formation. Botulinum toxin type A (BTX-A) is widely used for facial rejuvenation and many other medical indications. It is a potent neurotoxin that indirectly blocks neuromuscular transmission and leads to functional denervation of striated muscle for 2 to 6 months after injection. Recently, experimental study and clinical trails have revealed that BTX-A can inhibit the growth of fibroblasts derived from hypertrophic scars and influenced the expression of transforming growth factor-β1. Therefore, we hypothesized that BTX-A can improve hypertrophic scarring after epicanthoplasty through release orbicularis oculi muscle tension, inhibit fibroblast growth, and reduce collagen production. The main aim of this trail is to evaluate the efficiency of BTX-A injection on improving hypertrophic scaring after epicanthoplasty.

NCT ID: NCT03305861 Recruiting - Clinical trials for Prostatic Hyperplasia With Urinary Obstruction

Green LEP vs ThuLEP in Management of Marked Enlarged Prostate

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

In this study the investigators aim to test TGreenlight (532-nm) laser Photoselective Enucleation of the Prostate (Green LEP) using (XPS) 180W system ) vs Thulium Laser 200 W Enucleation of the Prostate (ThuLEP) in reduction of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) in a randomized controlled trial. Furthermore, all peri-operative parameters, urinary flow parameters, prostate size changes and complications associated with the procedures will be compared.